Eliem Therapeutics
(NASDAQ:ELYM)
$2.90
At close: Aug 9
$2.90
PreMarket: 4:35PM EDT
Day High/Low- - -
52 Week High/Low2.52 - 13.74
Open / Close- / -
Float / Outstanding8.1M / 26.6M
Vol / Avg.- / 126.6K
Mkt Cap77M
P/E-
50d Avg. Price3.62
Div / Yield-
Payout Ratio-
EPS-0.4
Total Float8.1M

Eliem Therapeutics (NASDAQ:ELYM), Quotes and News Summary

Eliem Therapeutics (NASDAQ: ELYM)

Day High/Low- - -
52 Week High/Low2.52 - 13.74
Open / Close- / -
Float / Outstanding8.1M / 26.6M
Vol / Avg.- / 126.6K
Mkt Cap77M
P/E-
50d Avg. Price3.62
Div / Yield-
Payout Ratio-
EPS-0.4
Total Float8.1M
Sector: Health Care.Industry: Biotechnology
Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-07
REV
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-09-12
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Eliem Therapeutics Questions & Answers

Q
How do I buy Eliem Therapeutics (ELYM) stock?
A

You can purchase shares of Eliem Therapeutics (NASDAQ: ELYM) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Eliem Therapeutics's (ELYM) competitors?
Q
What is the target price for Eliem Therapeutics (ELYM) stock?
A

The latest price target for Eliem Therapeutics (NASDAQ: ELYM) was reported by SVB Leerink on Monday, July 11, 2022. The analyst firm set a price target for 9.00 expecting ELYM to rise to within 12 months (a possible 210.34% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Eliem Therapeutics (ELYM)?
A

The stock price for Eliem Therapeutics (NASDAQ: ELYM) is $2.9 last updated August 9, 2022, 8:00 PM UTC.

Q
Does Eliem Therapeutics (ELYM) pay a dividend?
A

There are no upcoming dividends for Eliem Therapeutics.

Q
When is Eliem Therapeutics (NASDAQ:ELYM) reporting earnings?
A

Eliem Therapeutics’s Q3 earnings are confirmed for Monday, November 7, 2022.

Q
Is Eliem Therapeutics (ELYM) going to split?
A

There is no upcoming split for Eliem Therapeutics.

Q
What sector and industry does Eliem Therapeutics (ELYM) operate in?
A

Eliem Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.